Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Common Stock | Options Exercise | +7.44K | +2.07% | 367K | Jul 15, 2023 | Direct | F1, F2 | ||
transaction | GBIO | Common Stock | Tax liability | -$11.1K | -2.18K | -0.59% | $5.08 | 365K | Jul 15, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | GBIO | Restricted Stock Units | Options Exercise | $0 | -7.44K | -33.33% | $0.00 | 14.9K | Jul 15, 2023 | Common Stock | 7.44K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents the right to receive one share of the company's common stock. |
F2 | Includes 3,116 shares acquired under the company's employee stock purchase plan since April 18, 2023. |
F3 | On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. |